文献速递消化内镜消化道肿瘤与早癌

大型无蒂结直肠病变分块EMR后12个月首次监测结肠镜检查的安全性

Safety of first surveillance colonoscopy at 12 months after piecemeal EMR of large nonpedunculated colorectal lesions.
PubMed 文献 · Gastrointest Endosc · 2024-05-14

本研究回顾性分析前瞻性收集的数据库,纳入2019年8月至2023年4月本中心因≥20 mm无蒂结直肠病变行分块EMR并接受首次监测的患者,比较6个月与12个月监测组的复发率。结果显示6个月和12个月监测的总体复发率均为10.0%,12个月监测对选择性病变似乎可接受。

要点

  • 分块EMR后12个月首次监测的总体复发率为10.0%(10/100)。
  • 6个月监测组复发率为10.0%(46/461),两组复发率相同。
  • 12个月监测组病变更小、更多为锯齿状病变、更多采用冷分块EMR。

核心结论

  • 对于选择性≥20 mm无蒂结直肠病变,分块EMR后12个月监测似乎可接受。
  • 作者认为需要对选择性病变开展比较6个月与12个月首次监测的随机试验。

研究设计与样本

  • 本研究回顾性分析一个前瞻性收集的数据库,纳入2019年8月至2023年4月本中心所有转诊行内镜下切除的结直肠病变。
  • 共561个≥20 mm无蒂病变接受首次随访,其中443例患者的490个病变分配至6个月监测,65例患者的的71个病变分配至12个月监测。
  • 分配至6个月监测但直至10个月后才返回的24例患者的29个病变,其复发数据纳入12个月监测组。

主要发现

  • 12个月监测组病变较6个月监测组更小(平均大小25.9 ± 6.1 mm vs 37.0 ± 17.4 mm)。
  • 12个月监测组较6个月监测组更多为锯齿状病变(63.4% vs 9.6%),更多采用冷分块EMR(74.6% vs 20.4%)。
  • 6个月和12个月监测的总体复发率分别为10.0%(46/461)和10.0%(10/100)。
  • 6个月和12个月监测的平均复发大小分别为10.9 ± 6.2 mm和5.0 ± 3.1 mm。
  • 6个月监测组中1例患者在分块EMR部位发生癌,6个月或12个月监测的其他复发均无癌或高级别异型增生。

关键数值与推荐

  • 指南推荐≥20 mm无蒂结直肠病变分块EMR后首次内镜监测在6个月进行。
  • 12个月监测组病变平均大小25.9 ± 6.1 mm,6个月监测组为37.0 ± 17.4 mm。
  • 6个月监测组复发率10.0%(46/461),12个月监测组10.0%(10/100)。

临床怎么用

  • 对于选择性≥20 mm无蒂结直肠病变,分块EMR后12个月首次监测似乎可接受。
  • 作者认为需要对选择性病变开展随机试验比较6个月与12个月首次监测。

局限性

  • 本研究为回顾性分析。
  • 本研究数据来自本中心,原文未报告多中心数据。
  • 12个月监测组样本量较小(65例患者的71个病变)。
  • 作者认为需要对选择性病变开展随机试验比较6个月与12个月首次监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: After piecemeal EMR (pEMR) of nonpedunculated colorectal lesions ≥20 mm, guidelines recommend first endoscopic surveillance at 6 months. However, initial surveillance at 12 months may be adequate for selected low-risk lesions and could save the cost, risk, and inconvenience of 1 surveillance examination. METHODS: This study retrospectively examined a prospectively collected database of all colorectal lesions referred to our center for endoscopic resection between August 2019 and April 2023. We report recurrence rates of patients with colorectal lesions ≥20 mm removed by pEMR who were assigned to 6-month first surveillance or to 12-month first surveillance (or assigned to a 6-month surveillance visit but did not return until after 10 months). RESULTS: There were 561 nonpedunculated lesions ≥20 mm that underwent first follow-up, including 490 lesions in 443 patients assigned to 6-month surveillance and 71 lesions in 65 patients assigned to 12-month surveillance. Lesions assigned to 12-month surveillance were smaller (mean size, 25.9 ± 6.1 mm vs 37.0 ± 17.4 mm), more likely serrated (63.4% vs 9.6%), and more often removed by cold pEMR (74.6% vs 20.4%). Twenty-nine lesions in 24 patients assigned to 6-month surveillance presented after 10 months, and their recurrence data were included in the group assigned to 12-month surveillance. Overall recurrence rates at 6 months and 12 months were 10.0% (46 of 461) and 10.0% (10 of 100), respectively. Mean recurrence sizes at 6 and 12 months were 10.9 ± 6.2 mm and 5.0 ± 3.1 mm, respectively. One patient in the 6-month surveillance group had cancer at the pEMR site, but no other recurrences at 6 or 12 months had either cancer or high-grade dysplasia. CONCLUSIONS: Twelve-month surveillance seems acceptable for selected colorectal lesions ≥20 mm removed by pEMR. A randomized trial comparing initial 6-month versus 12-month surveillance is warranted for selected lesions.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bobay MC, Lahr RE, Shultz J, et al. Safety of first surveillance colonoscopy at 12 months after piecemeal EMR of large nonpedunculated colorectal lesions. Gastrointest Endosc. 2024. PMID: 38750975. doi:10.1016/j.gie.2024.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。